The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
Open accessAbstract
SUMMARY The JAK2V617F constitutively activated tyrosine kinase is found in most patients with myeloproliferative neoplasms. While examining the interaction between JAK2 and PRMT5, an arginine methyltransferase originally identified as JAK2 binding protein 1, we found that JAK2V617F (and JAK2K539L) bound PRMT5 more strongly than did wild-type JAK2. These oncogenic kinases also acquired the ability to phosphorylate PRMT5, greatly impairing its ability to methylate its histone substrates, and representing a specific gain-of-function that allows them to regulate chromatin modifications. We readily detected PRMT5 phosphorylation in JAK2V617F-positive patient samples and when we knocked down PRMT5 in human CD34+ cells using shRNA, we observed increased colony formation and erythroid differentiation. These results indicate that phosphorylation of PRMT5 contributes to the mutant JAK2-induced myeloproliferative phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Self-citationJAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276
Self-citationJak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy
Xue, Y., Ren, J., Gao, X., Jin, C., Wen, L., & Yao, X. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700574-mcp200 · Cited by 628
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R., & Kouzarides, T. (2009) · Nature · doi:10.1038/nature08448 · Cited by 622
Pal, S., Vishwanath, S. N., Erdjument-Bromage, H., Tempst, P., & Sif, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9630-9645.2004 · Cited by 592
Zhao, Q., Rank, G., Tan, Y. T., Li, H., Moritz, R. L., Simpson, R. J., Cerruti, L., Curtis, D. J., Patel, D. J., Allis, C. D., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1568 · Cited by 535
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
Ancelin, K., Lange, U. C., Hajkova, P., Schneider, R., Bannister, A. J., Kouzarides, T., & Surani, M. A. (2006) · Nature Cell Biology · doi:10.1038/ncb1413 · Cited by 464
Arginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Friesen, W. J., Paushkin, S., Wyce, A., Massenet, S., Pesiridis, G. S., Van Duyne, G., Rappsilber, J., Mann, M., & Dreyfuss, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8289-8300.2001 · Cited by 408
Mullally, A., Lane, S. W., Ball, B., Megerdichian, C., Okabe, R., Al-Shahrour, F., Paktinat, M., Haydu, J. E., Housman, E., Lord, A. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.015 · Cited by 395
Wernig, G., Kharas, M. G., Okabe, R., Moore, S. A., Leeman, D. S., Cullen, D. E., Gozo, M., McDowell, E. P., Levine, R. L., Doukas, J., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.009 · Cited by 390
Self-citationBranscombe, T. L., Frankel, A., Lee, J.-H., Cook, J. R., Yang, Z.-H., Pestka, S., & Clarke, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105412200 · Cited by 362
MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties
Le Guezennec, X., Vermeulen, M., Brinkman, A. B., Hoeijmakers, W. A. M., Cohen, A., Lasonder, E., & Stunnenberg, H. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.843-851.2006 · Cited by 340
Lu, X., Levine, R., Tong, W., Wernig, G., Pikman, Y., Zarnegar, S., Gilliland, D. G., & Lodish, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509714102 · Cited by 316
Self-citationProtein arginine-methyltransferase-dependent oncogenesis
Cheung, N., Chan, L. C., Thompson, A., Cleary, M. L., & So, C. W. E. (2007) · Nature Cell Biology · doi:10.1038/ncb1642 · Cited by 291
Pollack, B. P., Kotenko, S. V., He, W., Izotova, L. S., Barnoski, B. L., & Pestka, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31531 · Cited by 290
Hexner, E. O., Serdikoff, C., Jan, M., Swider, C. R., Robinson, C., Yang, S., Angeles, T., Emerson, S. G., Carroll, M., Ruggeri, B., et al. (2008) · Blood · doi:10.1182/blood-2007-04-083402 · Cited by 252
Akada, H., Yan, D., Zou, H., Fiering, S., Hutchison, R. E., & Mohi, M. G. (2010) · Blood · doi:10.1182/blood-2009-04-215848 · Cited by 249
Negative regulation of transcription by the type II arginine methyltransferase PRMT5
Fabbrizio, E., Messaoudi, S. E., Polanowska, J., Paul, C., Cook, J. R., Lee, J., Nègre, V., Rousset, M., Pestka, S., Le Cam, A., et al. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf136 · Cited by 237
A Novel WD Repeat Protein Component of the Methylosome Binds Sm Proteins
Friesen, W. J., Wyce, A., Paushkin, S., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109984200 · Cited by 233
An Assembly Chaperone Collaborates with the SMN Complex to Generate Spliceosomal SnRNPs
Chari, A., Golas, M. M., Klingenhäger, M., Neuenkirchen, N., Sander, B., Englbrecht, C., Sickmann, A., Stark, H., & Fischer, U. (2008) · Cell · doi:10.1016/j.cell.2008.09.020 · Cited by 232
Kwak, Y. T., Guo, J., Prajapati, S., Park, K.-J., Surabhi, R. M., Miller, B., Gehrig, P., & Gaynor, R. B. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00101-1 · Cited by 228
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
Xing, S., Wanting, T. H., Zhao, W., Ma, J., Wang, S., Xu, X., Li, Q., Fu, X., Xu, M., & Zhao, Z. J. (2008) · Blood · doi:10.1182/blood-2007-05-091579 · Cited by 213
Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs
Meister, G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf585 · Cited by 213
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
Zhao, X., Jankovic, V., Gural, A., Huang, G., Pardanani, A., Menendez, S., Zhang, J., Dunne, R., Xiao, A., Erdjument-Bromage, H., et al. (2008) · Genes & Development · doi:10.1101/gad.1632608 · Cited by 186
Self-citationWang, Y., Fiskus, W., Chong, D. G., Buckley, K. M., Natarajan, K., Rao, R., Joshi, A., Balusu, R., Koul, S., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-05-222133 · Cited by 177
Self-citationMyeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
Marty, C., Lacout, C., Martin, A., Hasan, S., Jacquot, S., Birling, M.-C., Vainchenker, W., & Villeval, J.-L. (2010) · Blood · doi:10.1182/blood-2009-12-257063 · Cited by 164
Wernig, G., Gonneville, J. R., Crowley, B. J., Rodrigues, M. S., Reddy, M., Hudon, H. E., Walz, C., Reiter, A., Podar, K., Royer, Y., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102186 · Cited by 145
Jak2: normal function and role in hematopoietic disorders
Ihle, J. N., & Gilliland, D. G. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.009 · Cited by 143
Richard, S., MOREL, M., & Cléroux, P. (2005) · Biochemical Journal · doi:10.1042/bj20040373 · Cited by 103
Rank, G., Cerruti, L., Simpson, R. J., Moritz, R. L., Jane, S. M., & Zhao, Q. (2010) · Blood · doi:10.1182/blood-2009-10-251116 · Cited by 98
Control of the DNA Methylation System Component MBD2 by Protein Arginine Methylation
Tan, C. P., & Nakielny, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-06 · Cited by 97
Chronic myeloproliferative disorders: a tyrosine kinase tale
Keersmaecker, K. D., & Cools, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404064 · Cited by 75
Pikman, Y., & Levine, R. L. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f0e20c · Cited by 8
Self-citation
Cited by
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
The regulation, functions and clinical relevance of arginine methylation
Guccione, E., & Richard, S. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0155-x · Cited by 625
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
Vainchenker, W., & Kralovics, R. (2017) · Blood · doi:10.1182/blood-2016-10-695940 · Cited by 616
The role of mutations in epigenetic regulators in myeloid malignancies
Shih, A. H., Abdel-Wahab, O., Patel, J. P., & Levine, R. L. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3343 · Cited by 611
Self-citation
Metadata
- Authors
- Liu, F., Zhao, X., Perna, F., Wang, L., Koppikar, P., Abdel-Wahab, O., Harr, M. W., Levine, R. L., Xu, H., Tefferi, A., Deblasio, A., Hatlen, M., Menendez, S., & Nimer, S. D.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 19
- Issue
- 2
- Pages
- 283-294
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2081473305
- Cited by
- 273
- References
- 39
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.